By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988




Alkermes plc 

Company News
Acceleron Pharma To Present At Upcoming Investor Conferences In February 1/28/2015 11:14:18 AM
Acceleron Pharma Outlines Corporate Objectives For 2015 1/12/2015 1:51:25 PM
Adimab LLC. Announces New Partnerships With Acceleron Pharma, Oncothyreon Inc. (ONTY), Surface Oncology And Potenza 1/9/2015 9:48:23 AM
Acceleron Pharma Added To NASDAQ Biotechnology Index 12/15/2014 10:23:06 AM
Acceleron Pharma Appoints Dr. Francois Nader To Its Board Of Directors 12/12/2014 8:33:10 AM
Acceleron Pharma Release: Luspatercept Data On Myelodysplastic Syndromes Selected For “Best Of ASH” By The American Society of Hematology 12/10/2014 10:18:34 AM
Acceleron Pharma To Present At Upcoming Investor Conferences In December 11/24/2014 10:37:05 AM
Acceleron Pharma Reports Third Quarter 2014 Financial And Operational Results 11/7/2014 9:33:23 AM
Acceleron Pharma Announces New Clinical Data Presentations At The 2014 American Society of Hematology Annual Meeting 11/6/2014 11:36:58 AM
Acceleron Pharma To Host Third Quarter 2014 Financial Results Conference Call And Webcast On November 7, 2014 10/30/2014 10:09:06 AM